Regulatory compliance - September 9, 2014
Novo Nordisk could get major fine
The company could get a fine of several millions for crimes against Russia’s competition law, reports Life Science Sweden. Russian competition authorities have found that Novo Nordisk could have breached the country’s competition law. The reason is reported to be a number of clauses in the company’s contract that limits competition. The purpose with the clauses […]
Pharma Business - September 2, 2014
Novo creates investment unit
Novo Nordisk’s holding company Novo A/S is setting up a new unit for major acquisitions that can invest ten billion DKK annually, according to web magazine News Øresund. The ambition is to buy companies within the pharmaceutical, biotech and medtech sector in the Nordic countries and other parts of Europe. “We have decided to construct […]
Regulatory compliance - August 22, 2014
Novo Nordisk accepts fine
The company has announced that it accepts fine for violating disclosure obligation in Denmark. Novo Nordisk A/S has accepted a DKK 500,000 fine imposed by the Public Prosecutor in a suit filed by the Danish Financial Supervisory Authority. In December 2013, the Danish Financial Supervisory Authority reported the company to the police for violating its obligation under […]
Financing - August 6, 2014
Novo Nordisk shares going steadily up
Danish Novo Nordisk shares are rising steadily this year, zooming past British competitor GlaxoSmithKline. Bloomberg recently reported that the company’s shares have gone up by 27 percent during 2014 with a total market cap of $120 billion, passing GSK by several billions which according to stock exchange experts comes as quite a surprise. Its 2014 sales forecast amounts to […]
Financing - June 26, 2014
Novo Nordisk to double revenue says deputy CEO
Danish drugmaker Novo Nordisk expects to double its annual revenue within the next ten years, according to deputy CEO Kåre Schultz. Novo Nordisk has had a tough year so far as the company failed to post double-digit sales growth in the first quarter for the first time in four years. But the results for 2014 might be a […]
Collaboration - March 31, 2014
Novo Nordisk launches diabetes program
Novo Nordisk has announced the launch of ‘Cities Changing Diabetes’, a new partnership program to fight the urban diabetes challenge. Initially, the program will be launched in Mexico City with other cities in North America, Europe and Asia soon to follow. “The global diabetes epidemic is an emergency in slow motion. While there are many factors […]
